Target intelligence / Profile preview

Ribosomal protein L17 pseudogene 39 (RPL17P39)

Target
RPL17P39
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L17 pseudogene 39 (RPL17P39) is a processed pseudogene in the human genome, meaning it is a non-coding DNA segment derived from the functional RPL17 gene. Although this locus retains an open reading frame similar to the original gene, it is not transcribed or translated into a functional ribosomal protein and does not participate in ribosome assembly or cellular protein synthesis. As with many ribosomal protein pseudogenes, RPL17P39 exists due to retrotransposition events and serves no known biological function. It is not considered a therapeutic target. Documentation and databases denote it simply as a pseudogene, and there is no indication of druggability, disease association, nor use as a biomarker in research or clinical practice[5][9][10][11]. Key points: - This entry is a pseudogene and not a functional protein-coding gene. - It is not involved in known biological functions or disease processes. - There are no drugs or mechanisms targeting this pseudogene. - The entry is not suitable as a therapeutic target and often appears in scientific databases for genomic annotation purposes only[5][10]. Related but distinct: - The functional gene RPL17 encodes a component of the 60S ribosomal subunit and has biological relevance, but RPL17P39 does not share these properties[8].

Other names
RPL17_14_1450hCG2004593RPL17P39[9]

Beyond the preview

Go deeper on Ribosomal protein L17 pseudogene 39 (RPL17P39).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L17 pseudogene 39 (RPL17P39).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call